Showing 478 news articles about New & experimental hepatitis C treatment

Filters Content type: Editors' picks Topic: New & experimental hepatitis C treatment

News and information about clinical trials and regulatory approval of new medications to treat hepatitis C.

New & experimental hepatitis C treatment

Recapitulation of the entire hepatitis C virus life in engineered mouse cell lines

Editor's pick
Eurekalert Medicine & Health
19 April 2012
New & experimental hepatitis C treatment

Treating Hepatitis C: Comorbidity of the Wallet

Editor's pick
BioPlus Specialty Pharmacy
17 April 2012
New & experimental hepatitis C treatment

More Hep C Drug Abstracts Leak Ahead of EASL Confab

Editor's pick
The Street
12 April 2012
Pharmaceutical industry

Gilead And The Future of HIV Therapy

Editor's pick
The Street
10 April 2012
New & experimental hepatitis C treatment

Winners, Losers From EASL Hepatitis C Data Dump

Editor's pick
The Street
10 April 2012
New & experimental hepatitis C treatment

What You Don’t Know, You Can Sell: Merck’s Cavalier Attitude Towards the Welfare of HIV/HCV Coinfected Patients

Editor's pick
TAG
10 April 2012
New & experimental hepatitis C treatment

Revised U.S. Guidelines Make Key HIV and Hep C Treatment Recommendations

Editor's pick
AIDSMeds
3 April 2012
New & experimental hepatitis C treatment

Copy of Revised U.S. Guidelines Make Key HIV and Hep C Treatment Recommendations

Editor's pick
Kaiser Daily Global Health Policy Report
3 April 2012
New & experimental hepatitis C treatment

Next-Generation HCV Protease Inhibitor Shows Promise

Editor's pick
Medscape (requires free registration)
29 March 2012
Hepatitis C treatment

NICE recommends Incivo for hepatitis C

Editor's pick
InPharm
20 March 2012
New & experimental hepatitis C treatment

Hepatitis C Phase 3 Trials Underway for TMC435

Editor's pick
Hepatitis Central
13 March 2012
New & experimental hepatitis C treatment

Merck's hepatitis C drug wins UK cost endorsement

Editor's pick
HCV New Drugs Research
9 March 2012
New & experimental hepatitis C treatment

NICE recommends Victrelis in speedy review

Editor's pick
InPharm
9 March 2012
New & experimental hepatitis C treatment

Good 12-Week HCV Suppression with Oral Telaprevir/VX-222/Ribavirin Combo

Editor's pick
HIVandHepatitis.com
27 February 2012
New & experimental hepatitis C treatment

European Medicines Agency informs doctors and patients about drug interaction between Victrelis and ritonavir-boosted HIV protease inhibitors

Editor's pick
European Medicines Agency
18 February 2012
New & experimental hepatitis C treatment

HCAB position statement: Hepatitis C drug development and drug-drug interaction studies

Editor's pick
EATG
18 February 2012
New & experimental hepatitis C treatment

Hard-to-Treat Group Trips Up Hepatitis C Drug

Editor's pick
MedPage Today
18 February 2012
New & experimental hepatitis C treatment

Gilead Drops as Patients Relapse on Hepatitis C Drug

Editor's pick
Bloomberg Business Week
17 February 2012
New & experimental hepatitis C treatment

Gilead Announces Data for Genotype 1 Null Responder Hepatitis C Patients Enrolled in ELECTRON Study

Editor's pick
Gilead press release
17 February 2012
New & experimental hepatitis C treatment

Drugmakers Jockey for Piece of Future Hepatitis C Combo Pill

Editor's pick
Bloomberg Business Week
15 February 2012
New & experimental hepatitis C treatment

Gilead, Vertex and the Mystery of Missing Hep C Patients

Editor's pick
The Street
13 February 2012
Drug interactions & pharmacokinetics

Combining HCV Med Boceprevir with Boosted HIV Protease Inhibitors Can Lower Drug Levels

Editor's pick
HIVandHepatitis.com
7 February 2012
New & experimental hepatitis C treatment

Gilead Gains on Positive Data From Experimental Hepatitis C Drug

Editor's pick
Bloomberg
3 February 2012
Pharmaceutical industry

Top Hepatitis C Virus Biotech Picks By The World's Largest Fund Managers

Editor's pick
Seeking Alpha
25 January 2012